Treprostinil Palmitil Inhalation Powder (TPIP) in Patients With Pulmonary Arterial Hypertension or Pulmonary Hypertension Associated With Interstitial Lung Disease
Latest Information Update: 10 Jun 2025
At a glance
- Drugs Treprostinil palmitil (Primary)
- Indications Pulmonary arterial hypertension
- Focus Expanded access; Therapeutic Use
- Sponsors Insmed
Most Recent Events
- 29 Apr 2025 New trial record